This case explores the difficulties entailed in commercialising vaccines in low income settings. The focus is the dengue vaccine, established at the end of 2015, which was first commercialised in emergent markets.
It considers issues of affordability and distribution, higlighting the need for business model innovation in all industries.
PUBLICATION DATE: January 25, 2016 PRODUCT #: IN1139-PDF-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
Goldfinger: Charles W. Engelhard Jr. and Apartheid-era South Africa
National Casualty Insurance
A Note on Trust
Financial Crisis in Asia: 1997-1998 (Abridged)
Reagan Plan, Spanish Version
Note on Angel Financing (2012)
Sociable Labs (A)
Envia Systems
Asia Alternatives, Approaching the Frontier
Cypress Semiconductor: A Federation of Entrepreneurs
